Biolight Life Sciences Ltdis An Israel Based Company Dedicated To Investing In And Managing Projects Focused On Eye Diseases And Ocular Treatmentsas The Only Company In Israel Specializing Exclusively In Ophthalmologybiolight Is A Leader In This Fieldit Is Publicly Traded On The Tel Aviv Stock Exchange Under The Ticker Symbol Bolt The Companyae S Portfolio Includes Advanced Medical Devicesmedicationsdiagnosticsand Digital Medicine Aimed At Addressing Significant Needs In Ophthalmologybiolight Develops And Commercializes Products That Enhance Diagnosis And Treatment Efficacy For Various Eye Conditionsincluding Glaucomadry Eye Syndromeand Age Related Macular Degenerationa Notable Product Is The Eye D Platforman Insertable Device Designed For The Controlled Release Of Ophthalmic Medicationswhich Helps Improve Patient Compliance With Treatments Biolight S Strategy Focuses On Expanding Its Portfolio Of Ophthalmic Technologiesparticularly Those Integrating Digital Medicinethe Company Collaborates With A Global Network Of Ophthalmic Specialists To Identify Medical Needs And Assess Potential Technologiespositioning Itself As A Key Player In The Ophthalmology Sector Both In Israel And Internationally
